Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00081-3/fulltext